MENU
NBIX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Neurocrine Biosciences (NBIX) Earnings Date & Reports

Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

NBIX is expected to report earnings to rise 39.77% to 97 cents per share on August 05

Neurocrine Biosciences NBIX Stock Earnings Reports
Q2'25
Est.
$0.98
Q1'25
Missed
by $0.07
Q4'24
Beat
by $0.12
Q3'24
Beat
by $0.29
Q2'24
Beat
by $0.50
The last earnings report on May 05 showed earnings per share of 69 cents, missing the estimate of 76 cents. With 15.43K shares outstanding, the current market capitalization sits at 13.72B.
View a ticker or compare two or three
NBIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a product based biopharmaceutical company

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Biotechnology
Address
12780 El Camino Real
Phone
+1 858 617-7600
Employees
1400
Web
https://www.neurocrine.com